U.S. firm Moderna, Japan's Takeda to seek vaccine approval

U.S. biotechnology firm Moderna Inc. is planning to file for the Japanese health ministry's approval of its novel coronavirus vaccine as early as Friday, several people familiar with the matter said Tuesday.The request would be the third such application for regulatory approval in Japan and will be filed with Takeda Pharmaceutical Co., Moderna's partner for its vaccine's clinical study and distribution in Japan.Takeda recently said it has finished the enrollment of study candidates in Japan for Moderna's COVID-19 vaccine in early February, aiming to gain government approval and start distri…READ FULL ARTICLE